Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Williams, WB; Jones, K; Krambrink, A; Grove, D; Liu, P; Yates, NL; Moody, MA; Ferrari, G; Pollara, J; Moodie, Z; Morgan, CA; Liao, H; Montefiori, DC; Ochsenbauer, C; Kappes, J; Hammer, S; Mascola, J; Koup, R; Corey, L; Nabel, G; Gilbert, P; Churchyard, G; Keefer, M; Graham, BS; Haynes, BF; Tomaras, GD

Published Date

  • September 2012

Published In

Volume / Issue

  • 9 / S2

Published By

Electronic International Standard Serial Number (EISSN)

  • 1742-4690

Digital Object Identifier (DOI)

  • 10.1186/1742-4690-9-s2-o55